Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cat-PAD Peptide Immunotherapy in Cat Allergy
NCT02311413Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2015
- Primary completion
- Jul 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Cat-PAD in cat allergy, sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2015; status: completed.
02
Drugs
Cat-PAD
03
Conditions
cat allergy
Beyond the preview
Go deeper on NCT02311413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02311413.